Key result
POLESTAR trial correction fixes an author name and adds missing supplementary material.
Answers are grounded in this paper and cite their sources.
No new clinical data reported; leaves open questions on early TAVI discharge safety with ACURATE Neo.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ooms et al. (2026) studied Transcatheter aortic valve implantation. ACURATE Neo was evaluated. This is a correction article fixing an author name and missing supplementary material for the POLESTAR trial; no clinical results are reported.
Synapse has enriched 10 related papers. Consider them for comparative context: